货号:GS40786
Verekitug is an investigational monoclonal antibody of the IgG1-kappa subtype that specifically targets Cytokine Receptor Like Factor 2 (CRLF2). It is developed with a primary focus on hematological malignancies, particularly B-cell acute lymphoblastic leukemia (B-ALL), where it aims to block the pathological signaling driven by CRLF2 overexpression or rearrangement.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯